Literature DB >> 16199889

Immediate and delayed effects of E-cadherin inhibition on gene regulation and cell motility in human epidermoid carcinoma cells.

Henriette Andersen1, Jakob Mejlvang, Shaukat Mahmood, Irina Gromova, Pavel Gromov, Eugene Lukanidin, Marina Kriajevska, J Kilian Mellon, Eugene Tulchinsky.   

Abstract

The invasion suppressor protein, E-cadherin, plays a central role in epithelial cell-cell adhesion. Loss of E-cadherin expression or function in various tumors of epithelial origin is associated with a more invasive phenotype. In this study, by expressing a dominant-negative mutant of E-cadherin (Ec1WVM) in A431 cells, we demonstrated that specific inhibition of E-cadherin-dependent cell-cell adhesion led to the genetic reprogramming of tumor cells. In particular, prolonged inhibition of cell-cell adhesion activated expression of vimentin and repressed cytokeratins, suggesting that the effects of Ec1WVM can be classified as epithelial-mesenchymal transition. Both short-term and prolonged expression of Ec1WVM resulted in morphological transformation and increased cell migration though to different extents. Short-term expression of Ec1WVM up-regulated two AP-1 family members, c-jun and fra-1, but was insufficient to induce complete mesenchymal transition. AP-1 activity induced by the short-term expression of Ec1WVM was required for transcriptional up-regulation of AP-1 family members and down-regulation of two other Ec1WVM-responsive genes, S100A4 and igfbp-3. Using a dominant-negative mutant of c-Jun (TAM67) and RNA interference-mediated silencing of c-Jun and Fra-1, we demonstrated that AP-1 was required for cell motility stimulated by the expression of Ec1WVM. In contrast, Ec1WVM-mediated changes in cell morphology were AP-1-independent. Our data suggest that mesenchymal transition induced by prolonged functional inhibition of E-cadherin is a slow and gradual process. At the initial step of this process, Ec1WVM triggers a positive autoregulatory mechanism that increases AP-1 activity. Activated AP-1 in turn contributes to Ec1WVM-mediated effects on gene expression and tumor cell motility. These data provide novel insight into the tumor suppressor function of E-cadherin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199889      PMCID: PMC1265771          DOI: 10.1128/MCB.25.20.9138-9150.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

1.  Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling.

Authors:  M van de Wetering; N Barker; I C Harkes; M van der Heyden; N J Dijk; A Hollestelle; J G Klijn; H Clevers; M Schutte
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

Review 2.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

3.  Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation.

Authors:  S Pece; J S Gutkind
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

4.  Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation.

Authors:  K Matsuo; J M Owens; M Tonko; C Elliott; T J Chambers; E F Wagner
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

5.  The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression.

Authors:  A Cano; M A Pérez-Moreno; I Rodrigo; A Locascio; M J Blanco; M G del Barrio; F Portillo; M A Nieto
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

6.  The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells.

Authors:  E Batlle; E Sancho; C Francí; D Domínguez; M Monfar; J Baulida; A García De Herreros
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

Review 7.  CDH1 germline mutation in hereditary gastric carcinoma.

Authors:  Hai-Dan Wang; Jun Ren; Lian Zhang
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

8.  Functional interaction between E-cadherin and alphav-containing integrins in carcinoma cells.

Authors:  M von Schlippe; J F Marshall; P Perry; M Stone; A J Zhu; I R Hart
Journal:  J Cell Sci       Date:  2000-02       Impact factor: 5.285

9.  Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of beta-catenin and upregulation of beta-catenin/lymphoid enhancer binding factor-1 transcriptional activity.

Authors:  A Eger; A Stockinger; B Schaffhauser; H Beug; R Foisner
Journal:  J Cell Biol       Date:  2000-01-10       Impact factor: 10.539

10.  E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner.

Authors:  C J Gottardi; E Wong; B M Gumbiner
Journal:  J Cell Biol       Date:  2001-05-28       Impact factor: 10.539

View more
  25 in total

1.  Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription.

Authors:  Laura Casalino; Latifa Bakiri; Francesco Talotta; Jonathan B Weitzman; Alfredo Fusco; Moshe Yaniv; Pasquale Verde
Journal:  EMBO J       Date:  2007-03-08       Impact factor: 11.598

2.  S100A4 mediated cell invasion and metastasis of esophageal squamous cell carcinoma via the regulation of MMP-2 and E-cadherin activity.

Authors:  Hong-Yan Zhang; Xian-Zhao Zheng; Xin-Hua Wang; Xiao-Yan Xuan; Feng Wang; Shan-Shan Li
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

3.  ZEB1-responsive genes in non-small cell lung cancer.

Authors:  Robert M Gemmill; Joëlle Roche; Vincent A Potiron; Patrick Nasarre; Michael Mitas; Chris D Coldren; Barbara A Helfrich; Elizabeth Garrett-Mayer; Paul A Bunn; Harry A Drabkin
Journal:  Cancer Lett       Date:  2010-10-25       Impact factor: 8.679

4.  Three-dimensional multispecies nonlinear tumor growth-II: Tumor invasion and angiogenesis.

Authors:  Hermann B Frieboes; Fang Jin; Yao-Li Chuang; Steven M Wise; John S Lowengrub; Vittorio Cristini
Journal:  J Theor Biol       Date:  2010-03-18       Impact factor: 2.691

5.  Nonlinear modelling of cancer: bridging the gap between cells and tumours.

Authors:  J S Lowengrub; H B Frieboes; F Jin; Y-L Chuang; X Li; P Macklin; S M Wise; V Cristini
Journal:  Nonlinearity       Date:  2010

6.  ZEB-1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells.

Authors:  Jonathan Clarhaut; Robert M Gemmill; Vincent A Potiron; Slimane Ait-Si-Ali; Jean Imbert; Harry A Drabkin; Joëlle Roche
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

7.  BAG3 regulates epithelial-mesenchymal transition and angiogenesis in human hepatocellular carcinoma.

Authors:  Heng Xiao; Shaobing Cheng; Rongliang Tong; Zheng Lv; Chaofeng Ding; Chengli Du; Haiyang Xie; Lin Zhou; Jian Wu; Shusen Zheng
Journal:  Lab Invest       Date:  2013-12-23       Impact factor: 5.662

8.  SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer.

Authors:  A Emre Sayan; Thomas R Griffiths; Raj Pal; Gareth J Browne; Andrew Ruddick; Tamer Yagci; Richard Edwards; Nick J Mayer; Hasan Qazi; Sandeep Goyal; Serena Fernandez; Kees Straatman; George D D Jones; Karen J Bowman; Alexandra Colquhoun; J Kilian Mellon; Marina Kriajevska; Eugene Tulchinsky
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

Review 9.  Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer.

Authors:  Geert Berx; Eric Raspé; Gerhard Christofori; Jean Paul Thiery; Jonathan P Sleeman
Journal:  Clin Exp Metastasis       Date:  2007-11-03       Impact factor: 5.150

10.  Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition.

Authors:  Jakob Mejlvang; Marina Kriajevska; Cindy Vandewalle; Tatyana Chernova; A Emre Sayan; Geert Berx; J Kilian Mellon; Eugene Tulchinsky
Journal:  Mol Biol Cell       Date:  2007-09-12       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.